← Leaderboards
Linda F Carson
University Of Minnesota Twin Cities
$66,074
Attributed
$66,074
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $15K · FY2005–09$20K$15K$10K$5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$66,074 · 6
By mechanism
M01$66,074 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Henry H. Balfour$14,130,793
- R Scott McIvor$12,592,678
- Daniel J Weisdorf$29,176,401
- Bernhard Josef Hering$29,197,217
- Daniel A Vallera$6,910,381
Others in their field
Top investigators on “Cisplatin”
- Philip J Disaia · University Of California Irvine$57,355,877
- Robert C Park · American College Of Ob And Gyn$16,339,593
- Aziz Sancar · University Of North Carolina Chapel Hill$11,887,517
- Manijeh N Goldberg · Privo Technologies, Llc$11,254,955
- Lois B. Travis · University Of Rochester$11,212,396
- Stephen J Lippard · Boston University Medical Campus$9,887,688
Research focus
CisplatinAdenocarcinomaTopotecanResearch PersonnelInstitutionAdjuvantSourcePelvisChemotherapyS HealthLiquid SubstanceReportingComputer Retrieval Of Information On Scientific Projects DatabaseContinuous InfusionMalignant Neoplasm Of Cervix UteriRadiation TherapyFlushingFundingGrantHourPumpResourcesStagingUnited States National Institutes Of Health
Grant awards (6)
CLINICAL TRIAL: WCC #34: PHASE I STUDY OF ADJUVANT TOPOTECAN/CISPLATIN & RADIATI$4,025
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: WCC #34: PHASE I STUDY OF ADJUVANT TOPOTECAN/CISPLATIN & RADIATI$15,018
M01 · FY2008 · RR · contact PI
WCC #34: PHASE I STUDY OF ADJUVANT TOPOTECAN/CISPLATIN & RADIATION - CERVICAL CA$10,473
M01 · FY2007 · RR · contact PI
WCC #34: PHASE I STUDY OF ADJUVANT TOPOTECAN/CISPLATIN & RADIATION - CERVICAL CA$5,738
M01 · FY2006 · RR · contact PI
WCC #34: PHASE I STUDY OF ADJUVANT TOPOTECAN/CISPLATIN &RADIATION - CERVICAL CA$13,077
M01 · FY2005 · RR
WCC #34: Phase I Study of Adjuvant Topotecan/Cisplatin &Radiation - Cervical CA$17,743
M01 · FY2004 · RR